Artie Rappaport

Artie Rappaport is the Founder of NON-INVASIVE MEDICAL SYSTEMS, LLC, a company dedicated to manufacturing and commercializing a portable device for measuring and monitoring elevated intracranial pressure (ICP) in a non-invasive and continuous manner.

The device has been successfully tested in a patient clinical study at Columbia University/NY Presbyterian Medical Center, demonstrating its efficiency compared to invasive intraventricular ICP monitoring.

With patents issued in the U.S., Japan, EU, China, and Israel, and pending in other countries, this non-invasive technology aims to revolutionize the care for traumatic and non-traumatic head injuries by providing immediate ICP assessment in various clinical settings.

The portable and user-friendly device can be administered by healthcare professionals like nurses, technicians, and EMTs outside traditional ICU settings, enabling quick and accurate ICP measurements on-site, such as in ambulances, battlefields, or sports fields.

This innovation offers numerous advantages for patients, healthcare providers, and the healthcare system, including early diagnosis, cost-effective treatment, reduced infection risk, and extended monitoring periods.

With a background in Bachelor's studies at City University of New York - CCNY, Artie Rappaport combines expertise in medical technology with a mission-driven approach to improving patient outcomes and streamlining healthcare processes.

For further information, Artie Rappaport can be contacted via email at artirap@noninvasivemed.com or on his cell at 914-462-0701.